These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3019268)

  • 21. Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims.
    Cheetham SC; Crompton MR; Katona CL; Parker SJ; Horton RW
    Brain Res; 1988 Sep; 460(1):114-23. PubMed ID: 2851368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls.
    Lowther S; De Paermentier F; Cheetham SC; Crompton MR; Katona CL; Horton RW
    J Affect Disord; 1997 Feb; 42(2-3):199-207. PubMed ID: 9105961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serotonin-2 binding sites in frontal cortex of suicide victims.
    Stanley M; Mann JJ
    Lancet; 1983 Jan; 1(8318):214-6. PubMed ID: 6130248
    [No Abstract]   [Full Text] [Related]  

  • 24. Depression and antidepressant therapy: receptor dynamics.
    Zemlan FP; Garver DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):503-23. PubMed ID: 2173022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing factor binding sites in cortex of depressed suicides.
    Hucks D; Lowther S; Crompton MR; Katona CL; Horton RW
    Psychopharmacology (Berl); 1997 Nov; 134(2):174-8. PubMed ID: 9399381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain 5-HT2 receptor binding sites in depressed suicide victims.
    Cheetham SC; Crompton MR; Katona CL; Horton RW
    Brain Res; 1988 Mar; 443(1-2):272-80. PubMed ID: 3359270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of action of antidepressants].
    Llorca PM; Reine G; Wolf MA
    Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain GABAB binding sites in depressed suicide victims.
    Cross JA; Cheetham SC; Crompton MR; Katona CL; Horton RW
    Psychiatry Res; 1988 Nov; 26(2):119-29. PubMed ID: 2853398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic and noradrenergic neurobiology of alcoholic suicide.
    Underwood MD; Mann JJ; Arango V
    Alcohol Clin Exp Res; 2004 May; 28(5 Suppl):57S-69S. PubMed ID: 15166637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims.
    Arranz B; Eriksson A; Mellerup E; Plenge P; Marcusson J
    Biol Psychiatry; 1994 Apr; 35(7):457-63. PubMed ID: 8018797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala.
    Hrdina PD; Demeter E; Vu TB; Sótónyi P; Palkovits M
    Brain Res; 1993 Jun; 614(1-2):37-44. PubMed ID: 8348328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
    Skolnick P; Layer RT; Popik P; Nowak G; Paul IA; Trullas R
    Pharmacopsychiatry; 1996 Jan; 29(1):23-6. PubMed ID: 8852530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients.
    Gos T; Krell D; Bielau H; Brisch R; Trübner K; Steiner J; Bernstein HG; Jankowski Z; Bogerts B
    Eur Arch Psychiatry Clin Neurosci; 2008 Dec; 258(8):513-20. PubMed ID: 18574609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls.
    Mann JJ; Stanley M
    Acta Psychiatr Scand; 1984 Feb; 69(2):135-9. PubMed ID: 6702476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminergic receptor binding correlates of suicide: methodological issues.
    Mann JJ; McBride PA; Stanley M
    Psychopharmacol Bull; 1986; 22(3):741-3. PubMed ID: 3025908
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.
    Lawrence KM; De Paermentier F; Lowther S; Crompton MR; Katona CL; Horton RW
    J Psychiatry Neurosci; 1997 May; 22(3):185-91. PubMed ID: 9183117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.